Skip to Main Content

In its latest bid to address the opioid epidemic, the Food and Drug Administration released a so-called final guidance document that is designed to help drug makers develop generic versions of abuse-deterrent painkillers.

By encouraging production of such medicines, the agency hopes to mitigate the extent to which individuals misuse opioids while simultaneously lowering prescription drug costs, a wider goal that FDA officials have adopted in recent months.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED
  • From Canada they know what’s right!!!! USA unethical and will make pain patients who abide by all the rules of pain contract and have never done anything wrong! It’s inhumane!

    #opioidhysteria #chronicpain #spoonies BIG NEWS FROM CANADA! Provence of British Columbia reversed CDC and PROP David Juurlink requiring all physicians TO TREAT ALL PAIN PATIENTS WITHOUT DOSAGE RESTRICTIONS and to stop EXCLUDING pain patients from their practices.

Comments are closed.